CancerNetwork
|
ConsultantLive
|
Diagnostic Imaging
|
Musculoskeletal Network
|
OBGYN.net
|
Physicians Practice
|
Psychiatric Times
|
SearchMedica
© 1996 - 2011
UBM Medica LLC
, a
United Business Media
company
Privacy Statement -Terms of Service -
Advertising Information
-
Editorial Policy Statement
FDA adds boxed warning to fezolinetant for rare serious liver injury
Published: December 17th 2024 | Updated: December 17th 2024The FDA has added a boxed warning for fezolinetant (VEOZAH; Astellas), highlighting the rare occurrence of serious liver injury in patients taking the menopause treatment.
Read More
FDA adds boxed warning to fezolinetant for rare serious liver injury
Published: December 17th 2024 | Updated: December 17th 2024The FDA has added a boxed warning for fezolinetant (VEOZAH; Astellas), highlighting the rare occurrence of serious liver injury in patients taking the menopause treatment.
Read More
2 Commerce Drive
Cranbury, NJ 08512